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Abstract
Background: Despite the increased prevalence of reversible contraception, global unintended pregnancy rates are
stable. Mistakes, method failures, side effects, alcohol, stock-outs, fears, costs, delays, myths, religious interference,
doctors with other priorities, traditions and lack of health professionals may all factor in. Yet these unintended
pregnancies ― nearly a hundred million annually ― cause much individual suffering, and in the long run, can
aggravate conflicts, poverty, forced emigration and climate change. Presently, non-poor women postpone childbearing
because of longer educational trajectories and careers. Sterilisations are therefore less often regretted or coerced. For
poor-resourced women with a completed family, an unwanted pregnancy often has serious consequences, including
crossing the (extreme) poverty line in the wrong direction, choosing an unsafe abortion, or even death. Caesarean
sections (CSs), which currently stand at around 23 million annually, are increasing. On an “intention-never-to-become-
pregnant-again” analysis, choosing a partial, and even more so a total bilateral tubectomy to be implemented during
an ― anyway performed ― CS is by far the most reliable and safe contraceptive choice compared to meaning to start
female or male sterilisation or any other contraceptive method later, and it reduces the chance of a future ovarian
carcinoma substantially. CSs make subsequent pregnancies more dangerous. Simultaneously, they provide convenient,
potentially cost-free opportunities for voluntary permanent contraception (PC): particularly important if there is no
guaranteed future access to reliable contraception, safe abortion and well-supervised labour.
Partial solution: Millions of women are within reach of attaining freedom from the “tyranny of excessive fertility”
when they have a CS. Therefore, any woman who might conceivably be of the firm opinion that her family will
be (over) completed after delivery should antenatally have “what if you have a CS” counselling to assess whether
she would like a tubectomy/ligation. Yet many are not provided with this option: leading to frequent regret,
more often than having been giving that choice would.
Conclusion: Withholding antenatal counselling about the option of PC for in case the delivery might become a
CS is very prevalent, yet often more medically risky, and morally questionable than when, even in labour, a doctor
sometimes decides in the absence of earlier counselling, considering numerous factors, to provide the choice to
undergo a concurrent sterilisation if s/he is convinced that would be in the patient’s best interest.
Keywords: Reproductive intentions, Unintended pregnancies, (Complications of) caesarean section, Ethics of
female permanent contraception, Sterilisation regret, Climate, Religion, Less-resourced circumstances, Cultural
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Background
It seems appropriate to have a fresh look at female per-
manent contraception (FPC): the most prevalent (18.9%)
contraceptive method globally; but on average little-used
in Africa, the Middle East and Europe [1]. To reduce the
global number of unintended pregnancies and associated
misery, a larger role for permanent contraception (PC)
would help. This will require a more proactive attitude
from health professionals, and organisational changes.
Reproductive realities have changed in favour of
permanent contraception
Women in well-resourced settings, and often the pros-
perous and more educated in developing countries, are
older compared to the previous generation when they
(and their partner) decide that their family is complete
[2, 3]. Increased age reduces the chance of regretted
tubal occlusion (TO) and method failure considerably
[4–8]. The proportion of mothers that accepts fatalistically
that there might be a few more pregnancies/children after,
say, age 36 ― which would also frequently interfere with
their career ― seems to have shrunk. It appears that
following the start of a new partnership (often with a
man with children) after divorce or widowhood few
older women do intend to have an extra set of children.
Child mortality, not seldom the cause of regretted PC, is
at a historic low in many areas [9]. In fact, the increased
use of reliable contraception for postponing, spacing and
limiting is in itself the most important single factor redu-
cing the mortality of mothers and their children [10–15].
If child mortality is high, it is risky to start PC the moment
the family is seen as complete, although that is often the
most, or only, workable opportunity [16–18]. It could
later, however, leave one with what is felt as too few chil-
dren or with no son or no daughter. When child mortality
is rare, families would be more prepared to take that
risk, resulting in much fewer unintended pregnancies/
deliveries/maternal deaths. This releases family means
for nutrition, attention, health care and education, as
well as for extra resources per child on a national level,
part of the demographic dividend [15]. If technically
possible, perhaps some of the extra national reserves
should be used for free of charge IVF after loss of a
child following TO: this probably would strengthen the
above virtuous circle. Even donors might become interested
(one mobile IVF team per country even per region for this
indication might be enough) if this approach would really
result in far fewer unintended pregnancies. Another
reason for the existence of large families is the need for
old age care the demographic dividend might make it
possible to organise a form of basic state pension.
TO never needs to be abandoned, unlike other methods,
e.g., for cardiovascular problems including high blood
pressure, breast cancer, heavy smoking, migraine, supply
interruptions, inability to pay and pharmaceutical interac-
tions, see Tables 1 and 2.
There is convincing evidence that removing part of the
tubes ― most likely the more the better ― significantly
reduces the incidence of ovarian cancer, one of the
deadliest malignancies [19–22].
More and more women have careers outside their
home, encouraging a decision on when they want their
Table 1 Advantages of tubal occlusions performed during caesarean sections compared to hysteroscopic tubal occlusions
performed later
1. A TO during a CS is immediately effective.
2. Patients can’t make post TO contraceptive mistakes.
3. No need to check months later (ultrasound or X-ray) whether the TO was successful.
4. When sutures are used during a CS (clips are irrational) the TO can be cost-free.
5. One can be absolutely certain that the patient is not already pregnant.
6. If the tubes are removed entirely ― easy during a CS ―, then method failure, including extra-uterine pregnancy, is extremely rare.
7. If the tubes are removed entirely ― easy during a CS ―, then the future ovarian cancer incidence is likely to decrease by about a third.
8. There exist no medical contraindications for a TO performed during CS.
9. Technically, the procedure is virtually always successful.
10. For women who turn out to deliver by CS and are certain that they want no more pregnancies, planning a TO during that CS will have a much
lower failure rate than planning to postpone the TO (or partner’s vasectomy) until some months after delivery.
11. If the tubes are just ligated, not removed, reconstructive surgery is possible.
12. After postpartum discharge, the woman/couple very likely never needs to worry about contraception.
TO Tubal occlusions, CS Caesarean sections
Planning a mini-laparotomy for soon after a vaginal delivery shares, mutatis mutandis, with a CS/TO, ― when compared to an hysteroscopic TO later ― the
advantages No. 1,2,3,5,6,7,9,11,12 and to some extent ― some postpartum bravery is needed, or theatre or staff might be not available ― No. 10. Compared
to a laparoscopic TO later the advantages No. 5,9,12 and to some extent 6,7 and 10 apply to a postpartum mini-laparotomy
Compared to a hysteroscopic TO, an interval minilap TO (clips are with that approach also irrational) has, mutatis mutandis, advantages No. 1,2,3,6,7 and 11. In
practice, many (perhaps 50%) hysteroscopic TOs seem to be performed under anaesthesia and not in an office setting, and they are in the US very expensive
even more expensive than laparoscopic TOs [39]
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childbearing years to end dependably, and most don’t
consider a termination of pregnancy (TOP) ― about 56
million annually and increasing in absolute terms, of
which about half are unsafe, and 73% are obtained by
married women [23] ― a triviality.
Presently, more women are self-confident and educated,
and therefore less likely, it seems, to be coerced into
having a TO.
Caesarean sections can be excellent occasions to
provide permanent contraception
In most parts of the world, caesarean section (CS) rates
are growing [24–26]. CS rates are higher if women are
older, have been treated for infertility and have higher
BMIs [27–30]. A CS, if it completes the family, provides
a very convenient, cost-effective and the safest ― possibly
even including vasectomy ― PC opportunity. Conversely,
a laparoscopic and also a “minilap” interval TO can
become somewhat more dangerous after a previous
CS because of adhesions [31, 32]. But more important
these interval procedures including hysteroscopic TOs
are in practise difficult to organise and therefore result
in much higher failure rates if analysed on an intention to
have PC basis [33, 34]. Similarly, non-implemented firm
intentions to have an “interval” vasectomy occur fol-
lowing perinatal pledges by partners.
About a quarter of women in the European Union
(EU) have their last child via a CS [25], while in the
United States (US) in 2013, 43.1% of women aged ≥35
years who delivered had a CS [2]. In 2012 an estimated
22.9 million CSs were performed worldwide, around
19.4% if the 118 million live births are used as denominator
[26]. If 10 million of those CSs would involve women
who would like to stop having children and 50% of
those would like and receive a TO and these women
were on average 32 years old, then, 5 million times 18
years is 90 million couple years of protection could be
generated per year, each year. This is twice what is created
by the approximately 160 million 3 monthly contraceptive
injections given annually and only a little less than
what is suggested by the 1.3 billion pill-strips supplied
yearly [1], ― while there would be far fewer failures, (hid-
den) costs and side effects. These CS/TO projections are
not completely unrealistic, it is about what happens in
Brazil and to a lesser extent ― perhaps explained by the
higher vasectomy rate there― even the US.
Table 2 Advantages of tubal occlusions performed during caesarean sections over interval reversible contraceptive methods
1. Immediately very effective, only a copper IUD has that advantage, and abstinence, a condom/diaphragm/coitus interruptus work also
immediately, but not very effectively.
2. Patients can’t make mistakes after starting the method.
3. Technically, the procedure is virtually always successful. While, for example, IUDs are sometimes misplaced or fear/panic/pain stops the insertion
procedure.
4. TO is never abandoned because of side effects, stock-outs or rumours.
5. The method never needs to be abandoned because the patient develops a contra-indication (e.g., high blood pressure, thrombosis, breast
cancer, latex allergy, migraine, cirrhosis, cholestasis, smoking, pelvic TB/actinomycosis, fibroids or forgetfulness.
6. One can be absolutely certain that the patient is not already pregnant.
7. If the tubes are removed entirely ― easy during a CS, ― then method failure, including extra-uterine pregnancy, is extremely rare.
8. If the tubes are removed entirely ― easy during a CS ―, then the future ovarian cancer incidence is likely to decrease by about a third, that is
probably a larger reduction than resulting from the use of combined oral contraception.
9. There exist no medical contraindications for implementation a TO during a CS.
10. When sutures are used during a CS (clips are irrational) the TO can be cost-free.
11. No further action is needed for method continuation as opposed to acquiring new pills, condoms or injections, replacing and removing IUDs or
implants.
12. Patients are independent of supply networks, i.e., there is contraceptive security. This also means that there are no more contraceptive costs.
13. For women who are antenatally certain that they don’t want to become pregnant again, peripartum TOs will be followed by much fewer
unintended pregnancies than will the patients’ intent to start a reversible method later.
14. The partner can’t sabotage the method (throw away the pills, not cooperate with “natural” contraception or condom use) and he does not need
to know.
15. After postpartum discharge, the woman/couple likely never needs to worry (again) about contraception.
16. Staunch Catholics will need to confess a TO as a contraceptive sin only once as opposed to the use of condoms, pills, rings or injections.
Women can’t be made to stop TO. Some priests demand removal of an implant or IUD on pain of sacrament refusal, but circumventing a
tubectomy with IVF is also a Catholic “sin” so priests can’t demand that.
TO Tubal occlusions, CS Caesarean sections
Mutatis mutandis, hysteroscopic TOs share with TO during CS six of the above advantages (i.e., No. 4,5,11,12,14 and 16) vis-à-vis reversible contraception
Mutatis mutandis, laparoscopic TOs share with TO during CS ten of the above advantages (i.e., No. 1,2,4,5,7 ― but not that easy, 8― but not that easy, 11,12,14
and 16) vis-à-vis reversible contraception
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Scar-related pregnancy complications are on the rise,
so much so that regional centres of excellence are estab-
lished to cope with them in the US for example [35–38],
therefore the prevention of unintended post-CS gesta-
tions is especially important, even more so under non–
high-tech circumstances. Induced abortions also can
become more dangerous (placenta praevia or increta,
weak scar, caesarean scar ectopic pregnancy) when the
uterus is scarred.
TOs implemented during a CS or just after a vaginal
delivery (8–9% of all deliveries in the US are combined
with a TO: involving around 15% of all deliveries of
second and higher children) have probably the lowest
FPC failure rates, the largest prospective study shows:
7.5/1000 procedures cumulatively over 10 years [7, 8].
Following ― non-electrocautery ― interval laparo-
scopic TOs this rate was shown to be 36.5/1000 [8].
There seems to be not much difference in typical preg-
nancy rates after a laparoscopic clip application and a
hysteroscopic TO [39, 40]. Interval tubal cautery is
very effective but increases the ectopic pregnancy rate
in the rare cases the method fails [8]. Following a peri-
partum bilateral total salpingectomy (BTS) the contra-
ceptive efficacy is very likely to approach 100% [7].
As mentioned, TOs with clips, rings, cautery or su-
tures ― just like having one or more children, lactation
and the use of combined hormonal contraceptives ―
reduces the subsequent ovarian cancer risk [7, 19]. Prob-
ably, a BTS, the fimbriae included, reduces the risk even
more [7]. The ovarian cancer protection effect of TO is
not, unlike that of hormonal contraception, associated
with some increase in the breast [41, 42] and cervix can-
cer risks nor the suspicion of an increased HIV acquisi-
tion/transmission risk (vide infra), nor, conversely, with
a decrease in colon and endometrial malignancies. Until
there are further ― preferably randomised ― studies
(however unlikely these are to be performed), the
American College of Obstetricians and Gynecologists
(ACOG) does not for the moment support changing the
TO methodology: i.e. surgeons are advised to continue
to observe and practice minimally invasive techniques
for FPC [43, 44]. Even so, BTSs during CSs and soon
after vaginal delivery would not need a larger incision,
would have not more complications and would prolong
the operation, on average, 10 min [7, 43, 44]. This
probably applies also to interval mini-laparotomies as
performed (often under local analgesia) in less-
resourced settings where ovarian cancer has an extra
serious prognosis. The issue is still debated but it is at
the stage that, when feasible, patients wanting FPC
should be counselled about the choice between a classic, a
hysteroscopic TO and a BTS or, even better perhaps, of-
fered inclusion in a randomised trial [44]. Noteworthy, in
routine practice premenopausal hysterectomies for benign
indications are increasingly combined with BTSs for
ovarian cancer prevention. For the foreseeable future,
performing opportunistic BTSs seems the most promis-
ing approach for reducing the ovarian cancer mortality
meaningfully, much better than screening and treating,
and certainly more cost-effective [45].
While in North America the TOP rates for unmarried
women are, if anything, higher than in Europe, for married
European women these are 2.7 times the North American
rates [23]. This is very likely related to PC because PC
(male plus female) is 6.4 times more prevalent in North
America (36.0%) than in Europe (5.6%) [1].
Finally, there are many areas where the (health) re-
sources are so limited and/or the costs of interval TO so
high that FPC can only be provided in practice for the
average woman, during a CS and maybe post-partum or
post-abortum [14, 16–18, 33].
Doctors ought to be stewards of finite healthcare
resources
Among other factors, political developments, new thera-
peutic options, aging or growing populations, enhanced
public expectations, HIV, Zika and shrewd, not seldom
unethical, marketing strategies could make health care
even more expensive, which might in turn affect the re-
sources available for basic health care and other areas of
public spending [14, 46, 47]. Therefore, providing PC in
combination with other procedures if the opportunity
presents itself makes financial and ethical sense as long
as there are few regrets [48]. Moreover, if the costs of
the typical failure and discontinuation rates of other
methods and the need for further medical attention are
taken into consideration, then, whether combined with
another operation or not, FPC and vasectomies (un-
acceptable in some cultures, fewer method failures, but
not immediately effective and pregnancies from irregular
partners occur) are often anyway the most economic
contraceptive options excluding perhaps, depending on
the circumstances, IUDs [10, 49, 50].
The smaller the desired families the more difficult
it is without PC to prevent unintended
pregnancies
With the current global total desired fertility rate of little
above 2 children per woman ― although governments
sometimes interfere [51] ―, most women (couples) will
spend 25–30 years trying not to become pregnant and
have on average around 0.8–1.0 TOPs [23, 52].
The development of a convenient, reversible, non-
client dependent, reliable contraceptive method with
few, if any, negative side effects is therefore a priority,
Nobel-Prize Worthy, and the-least-we-should-do, now
that landing a probe on a small lumpy comet, after travel-
ling 6.4 billion kilometres through the Solar System, is
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achievable and Higgs Boson has been sensed. Presently,
annually, an estimated 33 million ― and increasing ―
women worldwide experience an accidental pregnancy
while using contraception [23, 53]; more women than
would have been unhappy if the Boson had not been
found.
It seems likely that future generations will succeed in
making the inability to become pregnant the default
position (for men and/or women), i.e., starting a preg-
nancy would require some technical, administrative and
perhaps spiritual and ceremonial efforts. Though still
flawed in important ways ― it is still of little use to
women who want to postpone, space or who are
undecided ―, an easily accessible PC method after the
family is completed, with free IVF/reconstructive tubal
surgery/ICSI or artificial insemination with stored
semen for those that develop serious regret, appears in
theory a cost-effective, rational step in the right direction.
There are problems with the reversible methods
Implants and IUDs have large discontinuation rates, so
have pills, rings, patches and injections [54–58].
Even in the US in 2011, a country where PC is quite
prevalent (female 23.6%, male 12.7%) [1], or, with a dif-
ferent denominator, 47.3% of married couples (TO
30.2%; vasectomy 17.1%) [4], nearly half (2.8 million) of
the around 6.1 million pregnancies was unwanted or
mistimed and of those 54% is attributable to non-use,
41% to inconsistent or imperfect use, and 5% to contra-
ceptive failure [57]: reversible client-dependent methods
are of course very disproportionally involved [49]. Of the
4.0 million US births 1.5 million (40%) were at concep-
tion unintended of which 720,000 (18% of all births)
were not merely mistimed but the mothers involved had
not wanted the index pregnancy nor a pregnancy anytime
in the future [57]. Poor women had an unplanned birth
rate nearly seven times that of higher-income women
[57]: A tiered system in which women with money have
options and those who haven’t, more babies. This works
naturally also the other way round: unplanned pregnan-
cies often make women/families poorer.
The above is very unfortunate, but it would cause
hopefully pandemonium if the resulting TOPs, around
1.1 million in 2011 [58], would be as unsafe ― with a
case fatality rate of 1:192 ― as in sub-Saharan Africa
(SSA) [53]. In the US 5700 women would die annually,
and many more would have lifelong disabilities. However,
with the new US president, with Republican majorities in
the House, the Senate, and in two-thirds of the state
governors’ mansions and uncertainty about the future
composition of the Supreme Court a move to end Roe v.
Wade seems a possibility. Of course, many of the unin-
tended pregnancies in the US involve women whose
family is not completed but it demonstrates how
difficult it is to avoid unintended pregnancies without
PC. In fact, in countries where the proportion of
women using a contraceptive method very clearly out-
weighs the proportion with unmet need ― hopefully
the future everywhere ―, often the greatest numbers of
unintended pregnancies come about as a result of in-
correct or inconsistent use [14]. Long-acting reversible
contraceptives (LARC) perform better but need well-
trained often expensive health professionals, often in
poor-resourced countries in short supply.
While dispensing oestrogen-progestin combinations
requires from health staff the least effort, time, motivation
and training these methods have, apart from high typical
failure and discontinuation rates [14], not seldom non-
negligible side effects in the last 15 years of a woman’s
fertile lifespan [31, 59, 60]. Even the safest combination
is associated with 2.5 times the thromboembolism rate
seen in non-pregnant non-users of similar age and
health, while age (and of course smoking) has a large
impact on the a priori rate [31, 59]. This means that
the risk-benefit analysis for these combinations for a
specific woman will nearly always show that their use is
less dangerous than a pregnancy, but the risks com-
pared to using PC, increase with age. In some countries
with low PC rates many women above 40 years still
take the pill [60, 61], while in others there is often no
functioning sphygmomanometer in the clinics that supply
contraceptive tablets and/or injections.
Although 10–20% of users will discontinue LNG-IUS
because of side effects, the method, if affordable, is often
popular with completed families ― also because of the
positive side effects. For an undefined percentage of
Muslim/Orthodox Jewish/Animists families, LNG-IUSs
(and implants) are unacceptable because of the associated
cycle disruptions [62]. The non-evidence-based opinion
that the dominant mechanism of action of all, or only the
copper, IUDs is inducing abortions precludes their use for
a sizeable portion of monotheists.
Fewer women will develop endometrium cancer with
LNG-IUS use but, conversely, there might be a slight
temporary increase in breast cancer incidence of a simi-
lar magnitude as seen with oral contraception [63, 64].
If confirmed this will be one of the “developments”
mentioned in the title of this contribution.
Increasing cultural diversification
There is increasing diversity in many countries. Women
who hail culturally from, for example, Latin America,
The Caribbean, Suriname, India, Thailand, Iran, Cape
Verde, South-Africa, Turkey, North America or China,
where PC for a completed family is well-established [1],
might be reluctant even anxious to use (some of) the
unfamiliar, i.e., never used by their mothers and peers,
reversible methods entrenched and popular elsewhere,
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costs are also a factor [10, 14, 50, 56, 57, 65–69]. More-
over, the continuous motivation and discipline needed
for injections, condoms and pills are a problem for many
[14, 70, 71]. Alas it is very easy for women to find sup-
port for their anxieties on the internet. Doctors unfamil-
iar with providing specific methods like PC, IUDs or
implants often hide their lack of expertise by rubbishing
the method and tarnishing its reputation, sometimes for
years. Obstetricians and midwives might take it mis-
takenly for granted that immigrants or refugees who
would like a peripartum PC will in time take the initia-
tive. In many cultures vasectomies are unacceptable or
just rarely performed (Eastern Europe 0.2%, Africa and
Middle East both 0.0% prevalence) [1], leaving women
with contra-indications, side effects or “afraid of hor-
mones” [67] and with objections to devices in their wombs
[62], and without realistic access to interval FPC, no good
alternative. The above partly (confounded by income,
education and ethical/religious outlook) explains the
very large variations detected in well-resourced coun-
tries in TOP rates related to poverty and cultural back-
grounds [57, 65, 72–74]. These differences escalate with
repeat abortions [72–74]. At the same time immigrant
women in rich countries can have high, especially emer-
gency, CS rates [75]. Discussing the FPC option in time
during the antenatal period seems therefore mandatory,
but happens seldom in some countries [5, 48, 76]. High
abortion rates of immigrant women can also be mislead-
ing. They suggest that families are not larger than desired.
However, young women often give “religious reasons”, as
grounds for TOPs, i.e., pregnancies (or rather sexual rela-
tions) before marriage are not allowed. But older multip-
ara, also those with medical conditions warranting at least
thorough preconception care, mention “religious impera-
tives” often as reason for continuing an unintended and
unwanted pregnancy.
Without family planning one needs migration
planning
It has become apparent that fossil energy consumption
needs to be limited, and that land and water for food and
fuel production are finite and climate change will ― and
probably is already ― affect food security [11, 77–79].
Therefore, sustainable, equitable global development ―
including a catch-up operation for those left far be-
hind ― seems even more unrealistic if unintended
pregnancies ― 85 million annually, of which around
42 million (other studies find different numbers, e.g.
56·3 million [23]) become TOPs, and 32 million
(more than a quarter of all live-births) births [12, 53,
80] ― are not more successfully avoided. Most new-
borns “just replace” the deceased, but the 32 million
play a large part in population growth, including of
course those that are born earlier than intended
(mistimed). Alas, prominent climate activist Naomi
Klein in her important book “This Changes Every-
thing” [81] suggests a focus on population is a “dis-
traction” in the fight against climate change. For
many, mostly the rich, it is indeed a pretext not to
change their fuel burning lifestyle. However, the prob-
lems related to fast growing populations (migration,
war, poverty, unemployment, famine, national and
international political clashes and failed states) lately
also seriously distract governments and make it more
difficult to unite for climate change mitigation. Immi-
gration side effects affected the elections in the US
and very likely tipped the balance direction Brexit:
huge distractions. The immigration/refugees upheavals
are much less abstract for many voters than climate
change. Klein is also dismissing, against evidence to
the contrary, the estimated 225 million women in the
developing world, and those not well quantified in
well-resourced circumstances, who want to avoid
pregnancy and are not using a modern method of
contraception [1, 3–11, 80, 82], as a factor that needs
urgent addressing. For example, a study from Oregon
University claims that, in well-resourced circum-
stances, the lifelong climate-stabilizing efforts (vege-
tarianism, use of local products, (re)cycling, good
isolation, electric cars, solarpanels, windmills, no air
miles, etc.) of twenty people are cancelled out by the
birth of one extra child [83]. It follows that in the US
the dedicated lifetime climate-conserving efforts of 14
million people are neutralised as the result of the
above-mentioned 720,000 unintended, not merely
mistimed, births resulting from contraceptive failure
and non-use every year, [57, 84–87]. A study commis-
sioned by the UK-based charity Population Matters
together with Lancaster University asserts: “Reducing
future energy demand by preventing unwanted births
and hence lifetimes in developed as well as develop-
ing countries is far cheaper — US $1.11 per ton reduc-
tion in CO2 emissions — than any renewable energy
alternative. The benefits multiply in perpetuity via each
never-existing person’s never-existing descendants” [88].
More people means more fossil fuel intensive fertiliser
use, irrigation, heating, vicious circle air conditioning, and
transport, and less room for biofuel production (probably
needed for sea and air transport for a long time to come,
even after cars are powered renewably electric) because it
competes with food production, not to mention nature.
Klein’s position is possibly an attempt not to antagonise
the Vatican, a powerful climate ally. It is estimated that
the Catholic Church operates more than 5300 hospitals
worldwide [89], representing both an enormous amount
of alleviated suffering, and unnecessary misery on the in-
dividual and collective level by undermining modern
contraception and sex education via all possible platforms
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[11, 90, 91]. A recent example, women in some regions in
Latin America were told by health officials to postpone
pregnancy because of Zika, and regional religious officials
told them, not publicly contradicted by the Vatican, not to
use modern contraception and have, regarding the poor,
often the influence to make them. Especially poor families,
unable to access affordable health care and paid sick leave,
will suffer enormously raising a child with microcephaly,
and there is of course the suffering of the child. Why does
the ACOG or the Polish College not advise its members
to boycott hospitals that refuse to allow perinatal sterilisa-
tions or the provision of other modern contraceptives for
that matter?
An estimated 230 million births annually (1.7 times
the number of livebirths) and 270,000 maternal deaths
are already “sinfully” averted by current global contra-
ceptive use [12], imagine the sin-generating misery if
they weren’t. Another 21 million births (and at least 26
million TOPs) would be probably avoided if the unmet
need for contraception was satisfied [80]: more if people
had access to a more effective method mix, including PC
[92]. In Latin America 56% of the pregnancies are un-
intended apparently the highest rate of all continents
[53, 80]. This is no doubt intimately related to the de-
sire for small families combined with the traditions
and habits formed under a strong religious influence,
e.g., non-evidence-based opinions about the serious
dangers in this and the next life of using modern
contraception. However, although still mostly illegal,
TOPs (estimated 6.6 million [23] in Latin-America) are
unlike in the past ― church is now ignored and miso-
prostol available ―, rather safe, about as safe as in
Eastern Europe and in fact, significantly less dangerous
than women bringing their pregnancies to term [53].
It seems also likely that the Vatican’s attitude to mod-
ern contraception is considered by other major religions
as partly an attempt to consolidate or increase power by
numbers. This stimulates in my opinion, it is very difficult
to prove, an extra pronatalist attitude of non-Christian ―
even protestant (certainly in the past) ― religious
leaders. This would make the Vatican, for many out-
siders representing Christendom, partly responsible for
the climate-change and population-pressure-related mis-
ery. Besides, it is also not implausible that immigrants
with high fertility rates will encourage higher birth rates
of the locals in an attempt to preserve the dominant
culture (“Leitkultur”).
There are large regions where, among other factors,
the density and rapid increase of the population impede
for many access to the basics of a decent life, and where
climate change might push many more over the brink
[93]. If degrading plots or grazing areas have to be
shared by successive burgeoning generations (1 hectare/
household, 25 years later ½ hectare/household, 25 years
later ¼ hectare etc.) and there are few other income-
generating opportunities, then grinding misery seems
unavoidable if total fertility rates stay (much) higher than
two. Even more so if child bearing is not postponed to
later in life and therefore 3–4 generations have to live
simultaneously from the same food source instead of
2–3. This is the case in much of Africa, non-oil rich
Middle East, Afghanistan, Pakistan, and areas of India,
Latin America and the Philippines. The 48 Least Developed
Countries (LDCs) had an estimated population of 954
million in 2015, this is projected to double to 1.9 billion
persons by mid-century and increase to 3.2 billion in
2100 [94], while the number of women with an unmet
need for modern contraception is increasing in those
very countries [50].
One should also mention that areas with high birth rates
and, therefore almost by definition with many un-
employed men of military, criminal gang and drug-cartel
age, tend to be in turmoil. This is no doubt related to the
current refugee tragedies [85, 93]. There are according to
the UNHCR more than 65 million forcibly displaced
(refugees, asylum seekers and the internally displaced)
people ― the largest number since the Second World
War and four times more than a decade ago. Besides,
military actions burn much fuel and insurgencies interfere
with, for example solar farms or conservation projects.
Not only can rapid population growth and climate change
related droughts [93] and coastal submersions [85] result
in (civil) war, in addition loss of all hope for the future at
home also creates refugees [78]. It seems, for example,
elementary to try leaving Nigeria (and/or to have an
offshore nest egg) if the population will indeed increase
from 182 million in 2015 to, medium variant, 752 million
in 2100 while oil income will probably evaporate even
more and while there are already many very poor, mal-
nourished and hungry Nigerians [94, 95]. The above
population projections could easily be underestimates
because use of modern contraception has not increased in
the period 2008–2013 in Middle and West Africa while
the above projections assume decreasing fertility rates
[11, 49]. Conversely, the associated future increased
mortality might cause overestimation. Increasing Mediter-
ranean tragedies seem a given.
When state authority fails like in some sub-regions in
Latin America, Afghanistan, Central African Republic,
Mali, Burkina Faso, Yemen, Haiti, Iraq, Syria, South
Sudan, Chad, North-East Nigeria, North-East Kenya,
East Pakistan, Libya, Burundi, the Democratic Republic
of Congo, Ivory Coast and Somalia, it is often too late,
even downright dangerous, to (re)start a reproductive
health programme [96] while warlords, factions and
ministries of defence need cannon fodder (51), and also
more radicalised religious interpretations might threaten
contraception providers.
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In, for the time being, still well-resourced circum-
stances, however, the feared decrease in productivity
(and military capability) and the aging of the population
as result of low birth rates and increasing life expectancy
will possibly be resolved by robots ― if not by the (chil-
dren of) refugees who might take some time to adjust to
the (re) productivity in their new homes [65, 72]. Besides,
although Japan is an extreme example of an aging popula-
tion, and resists immigration and is very active in robot
development, it seems that hundreds of millions would be
quite happy with the Japanese standard of living.
Currently, of course, almost everywhere, (youth)
unemployment is a much larger problem than lack of
personnel. In any case an economic model with ever-
increasing productivity and consumption needing, and
at the same time driven by, a growing population, seems
for the foreseeable future unsustainable [81]. Professionally,
for doctors, midwives and nurses the low-hanging refugee/
climate-change/malnutrition/misery/failed-state and war
prevention fruits seems to be assisting patients optimally
to prevent unintended pregnancies, i.e. this is probably a
much more effective contribution than exchanging a SUV
for a Prius. One could argue there is a moral imperative
for the above fruit harvesting because “Medical science
bears much responsibility ― albeit without intent ― for
the population “explosion” of the past 200 years” [11].
Many a misery prevention opportunity, including pro-
viding the option of PC in case of CS or vaginal delivery,
is missed [5, 14, 18, 90].
TOs delayed are often TOs denied
Frequently, if women and their partners have used
reversible contraceptives for 5–20 years or so, followed,
often in quick succession, by two successful pregnancies,
then, for many, but for the fact that first an operation is
needed, being protected by a vasectomy or TO is a de-
sirable state of affairs. A small study ― of course not
randomised ― in the Netherlands showed that women
depending on PC were the most satisfied contraceptors
[97] and an Australian study found― “should be included
in the counselling” ― improved sexual lives of women
having undergone TO [76].
Globally, there is however a shortage of 2.2 million
surgeons, anaesthetists and obstetricians [98]. It is esti-
mated that the global needs-based shortage of health-care
workers will be more than 14 million in 2030. Billions do
not have access to safe, affordable surgical and anaes-
thesia care when needed, let alone the provision of
implants, IUDs, safe abortion, postpartum and interval
PC, which is very often not perceived by health staff,
mistakenly in my opinion, as an attention demanding
emergency [92, 96, 98, 99]. Just within the EU there are
vast inequalities in access to reproductive health goods
and services [66]. The lack of well-trained contraception
providers is particularly severe in regions with a high
burden of unsafe abortion.
Even under better-than-average conditions it is not
easy for a woman to realise an interval TO because of
anxiety, costs, travel, lack of facilities and confidentiality,
bureaucracy, time off work needed and loss of income.
In comparison, it is rather easy to improve knowledge,
attitudes, guidelines, software and practices related to
opportunistic TOs. To pressure a woman to have a con-
current TO if she will undergo a CS anyway is nearly
[100] always unacceptable [76, 96, 101, 102]. Yet denying
women/couples that choice is routine in many areas, espe-
cially in continental Europe, many Islamic countries and
in non-southern Africa [1, 5, 17, 18, 76, 92, 96, 101, 102].
This is also a form of coercion. Curiously, this compulsion
doesn’t result in litigation, public protest or disciplinary
boards. Test cases are urgently needed. For example, con-
cerning a 40-year-old woman who completed her family
via a CS without being provided with the TO option, and
who later because of a scar-related placenta accreta had a
life-threatening delivery, TOP or miscarriage, or a fatal
pulmonary embolism on the pill. Moreover, reproductive
coercion in the form of non-consensual sexual intercourse
or sabotaged contraception, pregnancy pressure and con-
trol of reproduction by an authoritarian, patriarchal or
abusive partner [103], or refusal of a Catholic hospital to
allow TO with a CS, or political interference with access
to contraception or safe abortion, is much more prevalent
[51, 91]― although not an excuse for health professionals
to also flout ethical standards― than coerced PC.
A TO has obviously one large disadvantage: it is diffi-
cult or impossible, depending on the circumstances, to
have more children if a woman changes her mind. On
the other hand, in the unlikely event that it would be
possible in future to close the tubes ― or vasa deferentia
for that matter ― via a reversible mechanical system
without increasing failure rates, side effects and costs,
then the ovarian cancer prevention advantage of TO
would disappear.
It is initially frequently better to introduce FPC in a
specific country, sub-culture, hospital or religious
denomination if one starts with CS/TO. It is easier to
accept, even for health staff, because there is often ―
especially with repeat CSs ― a medical-indication aspect
to it [35–38], and no extra resources are needed.
Women can often tell their mothers-in-law, peers, hus-
bands and confessors quite truthfully that the doctor
thought it safer not to have more pregnancies. In
Ireland, the Dutch Catholic (before that the protestant)
hospitals, Brazil and southern Africa and probably many
more places this stimulated the initial approval of FPC
by ― even religious ― opinion leaders. That was
followed by the acceptance of interval TO as one of the
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reasonable contraceptive options. Before that, quite
some, mostly well-to-do, women had to assert in desper-
ation, and the gynaecologist often knew they pretended,
that they had, for example, debilitating periods, in order
to qualify for a hysterectomy with as “side effect” PC. A
more dangerous, operation of course, with more subse-
quent side effects. In Ireland, when non-“natural” family
planning was still illegal, quite risky caesarean-
hysterectomies were performed more frequently than
seemed medically indicated to circumvent the Church’s
dictates [104]. Perhaps the realisation that TO reduces
the ovarian cancer risk will stimulate a reappraisal of
FPC in some countries.
In well-resourced settings, hysteroscopic TOs ― to be
implemented at least six weeks post-delivery ― are
currently commonly put forward by obstetricians as
the smart, better timed and considered, office-based,
non-surgical option, and therefore more preferable
than peripartum TOs, for those soon to have a completed
family [5, 33, 48]. However, although a good solution for
some, as mentioned their failure rate is much higher espe-
cially if analysed on an intention to treat basis [33, 34]. A
TO method that requires optical instruments is anyway
less suitable for introducing PC in a specific country, also
because of the training, capital outlay and disposables
needed ― to be recuperated via the patient one way or
the other ― and maintenance of equipment required.
Moreover, a few complications can ruin the acceptance of
this method, or perhaps even TO in general, in a certain
area for years. Hysteroscopic TOs have lately a somewhat
negative professional and lay press [39, 40, 105] which will
reduce the number of women actually turning up for PC a
few months after a delivery even more.
Similarly, many US Medicaid beneficiaries (a very large
proportion of women who deliver) miss a desired peri-
partum TO due to all sorts of cumbersome barriers/red
tape/misplaced forms and are when Medicaid runs out,
soon after delivery, unable to afford a TO or any other
reliable method ― higher income women do not
encounter this obstacle [106, 107]. The protocols/admin-
istrative hoops are meant to protect minorities, women
with mental problems and the intellectually challenged.
Very understandable in the light of what happened in
the past with eugenic TOs. However, medical ethical
standards have since evolved considerably in many juris-
dictions and these rules, probably, do now more harm
than good [106]. The fallout is estimated in the US alone
to be up to 62,000 unfulfilled requests for postpartum
sterilization, 10,000 abortions and 19,000 originally un-
intended births annually, at a public cost of $215 million
[17, 106]. Another US analysis showed that nearly 50%
of women who missed an intended peripartum TO ex-
perienced an unintended pregnancy within a year [107].
Correspondingly, denying a woman in Oregon, USA
who asks for an abortion because of a completed family
a concurrent TO, results on average, over the next five
years, in 1.3 unintended pregnancies and an additional
$4,152 in direct medical costs, a computer simulation
indicated [108].
Planning and counselling
In general, health professionals ― GPs, obstetricians,
midwives, paediatricians, psychiatrists, geneticist, district
doctors, neurologist, dermatologists, oncologist, infec-
tious disease specialists, cardiologists, rheumatologists,
urologists, health visitors, refugee support staff [109],
surgeons [110], etc. ― need to assess the reproductive
intentions of their patients. Perhaps they can help pre-
serve gametes or prevent unintended pregnancies,
pharmaceutical interactions with hormonal contracep-
tion, congenital abnormalities, unhappiness and/or the
interruption or termination of education.
Providing the option of a TO, should a CS later turn
out to be necessary, requires, if at all possible, some
weeks before the due date, routine, gentle, delicate
checking whether perhaps the patient/couple is of the
firm opinion that, if all goes well in the near future, the
family is thought to be complete. If that is indeed the
case, proper further counselling is needed and reviewed
not long before and even during the actual delivery in
the light of the then-available information. Counselling
includes in some countries with misinformation about this
subject in every supermarket, talking about cat food and
the difference between castration and TO [see, Fig. 1].
The TO counselling should be standard procedure in
most third trimester pregnancies according to the Inter-
national Federation of Gynecology and Obstetrics
(FIGO)’s Committee for the Ethical Aspects of Human
Reproduction and Women’s Health [96, 101]. The discus-
sion should be subtle because some women/couples see
this as an intrusion of their privacy and/or a sign of disap-
proval if they have more children than the local average,
or as distrust of their parenting abilities, or, if there is a
difference in background, even as a sign of racism, or reli-
gious or HIV discrimination. If the relevant mothers ―
e.g. in the EU, 53% of the women seen in the antenatal
clinics are expecting their ≥2 child [25] ― know that this
checking is routine ― just like inquiring after smoking,
breast feeding intentions or suggesting a HIV test―, then
few will feel insulted. There are also women who volun-
teer, following the slightest encouragement, especially
when they expect their ≥3 child that the pregnancy was
unintended and that they certainly don’t want even more
children.
In circumstances where a hysteroscopic, laparoscopic
or minilap TO some weeks-months after delivery is in
theory a feasible option, obstetricians/midwives should
be very clear antenatally when counselling prospective
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TO candidates: interval TOs have much higher failure
rates than peripartum TOs, overwhelmingly so if analysed
on an antenatal intention-to-have-PC-before-ovulation-
returns basis, also because they are often much more
expensive [18, 33, 34, 48]. In the Netherlands, a hystero-
scopic TO costs at least €1450 including follow-up (the
net monthly wage of a junior police officer/junior doctor,
and the procedure (unlike IVF) is not covered by most
(mandatory) insurance plans, just like the other reliable
contraceptive methods are not. Ironically, TOPs are paid
for by the state. In the US, the median of the total charges
for a hysteroscopic TO is an unbelievable $7832, and for a
laparoscopic TO $5068 [39]. One can imagine some
patients getting rather disturbed if the obstetrician or
hospital [106, 107] had denied them the CS/TO choice.
The doctor could also have a financial conflict of interests.
Sometimes a TO counselling opportunity arises if a
woman is to have an ovarian cystectomy, a cholecystec-
tomy (gallstones classically bother fairish, fortyish, fertile
females), removal of a perforated IUD, treatment of a mis-
carriage or extra-uterine pregnancy, or bariatric surgery ―
the latter also a good idea because after, depending on the
type, such surgery, absorption of oral contraceptives can be
reduced, and unintended pregnancies because of unantici-
pated restored fertility and perhaps resumed dating,
occur frequently and are not without risk [110].
In many, but not all [76, 111], studies, interval proce-
dures have somewhat lower regret rates than perinatal
TOs. However, most of these studies are somewhat
dated and therefore they involve women on average
younger and perhaps less self-confident therefore more
coercible than in general would presently be the case.
Moreover, only the very keenly motivated (sometimes
prepared to pay €1450―$7832), tenacious and rather
courageous will succeed, often against odds, in having
an interval TO. This in itself could explain lower interval
TO regret rates. Using this difference in TO regret rates
as an argument to discourage CS/TO will of course dra-
matically increase the missed-a-TO regret rates. TO
soon after a vaginal delivery still requires courage and
often payment, but other barriers like transport, lack of
baby sitters, difficult communication, exposure to
strangers and unfamiliar surroundings are less in evi-
dence and moreover BTS is easy and that will result in
optimal ovarian cancer prevention. Besides, coercion is
quite unlikely [96].
Sometimes, specifically in areas with few resources,
the removal of a retained placenta after a vaginal de-
livery in a woman of high parity, if she has anaesthesia
anyway, can be combined ― especially when antenatal
assessment of her reproductive intentions revealed
that her family is (more than) complete ― with a TO/
Fig. 1 Dastardly subtle, misleading, anti-sterilisation publicity seen in every supermarket in Belgium and France. Apparently after “sterilisation”
mammals need a special diet otherwise they become fat and indolent. Not exactly innocent when nearly half of the European adults have
“inadequate” or “problematic” health literacy [170]
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BTS via a mini-laparotomy. Adherent placentae often
recur in subsequent pregnancies and can result in
catastrophic bleeding. Ectopic pregnancies are also
seen in women of high parity with completed families,
and there is a serious risk of recurrence.
How to balance the risk of unintended (sometimes
dangerous) pregnancies later with the risk of regretted
PC is in theory easiest addressed by giving the relevant
women/couples the choice, after proper counselling
[96, 106]. Yet, sometimes giving a clear recommendation
based on a reasonable understanding of a woman’s own
preferences and potential future risks is preferable, for
which the term ― extra suitable in this case ― ma-
ternalism, as opposed to paternalism, has been
coined. [112, 113]. A study in the Netherlands, where
women on average have their first child when they
are 29.4 years ― average EU 28.7, Spain, Italy and
Switzerland >30 years [3] ― demonstrated that a pol-
icy of not initiating counselling about a potential TO
in combination with a potential CS for the ≥2 child,
was 62 to 186 times more likely to end in regret,
than facilitating an informed choice did [76]. An
American College of Obstetricians and Gynecologists
report shows that at least 25 times as many women
with an unmet wish for a peripartum TO have an un-
intended repeat pregnancy within a year than women
over 30 years of age who obtained PC develop such
serious regrets that they later elect to have a reversal
[107]. Facilitating the desire for a TO and paying for
the occasional IVF is likely to cause the greatest hap-
piness to the greatest number of women, plus it will
be often cost-effective.
The best approach for obstetricians and midwives who
fear that women/couples often have too little time (e.g.
CS of a 36-year-old Para 2 for a failed induction of a
post-dates pregnancy, or for mild hypertension; or an
unexpected large breech presentation with beginning
contractions at 39 weeks) to decide about a concurrent
TO, is to make early “what if you need a CS” antenatal
counselling a routine.
Young age, substance misuse, medical indications for
TO, coercion and unstable relationships are associated
with an increased incidence of TO regret. Regret is how-
ever frequently related to unanticipated events (divorce,
death of partner or child) which, in prosperous countries
with routine extensive antenatal foetal ultrasound
screening and even non-invasive prenatal DNA tests
can’t be much better anticipated ― except in cases of
prematurity when more caution is advised ― a few
months post-delivery than during a CS with a paediatri-
cian in attendance to quickly check the new-born [114].
Early counselling is frequently impossible to achieve in
less-resourced circumstances where patients tend to ar-
rive unbooked, often via a clinic and in labour, in
hospitals capable of performing CSs. Nevertheless, under
those circumstances the consequences (vide infra) of a
missed TO opportunity, not in the least because there is
in the meantime a scar in the uterus, are much more
often dangerous [18, 38]. One wonders however ― data
are impossible to obtain ―, how often counselling, that
is respecting a woman’s autonomy, whether well-timed
or not, occurs in the different European FIGO member
countries [47, 76]. The antenatal software, or the pre-
printed paper dossier, could easily be made to give a
suitable prompt around, say, 34 weeks.
Troublingly, if the patient was indeed presented with
the PC option or succeeded in taking the initiative, quite
some hospitals and/or obstetricians and/or anaesthetists
insist on a fee for a concurrent TO, as if two separate
operations are needed. Poor multiparae, including immi-
grants [74, 75], for whom LARCs are often also too ex-
pensive, or too scary, become the victims of these
questionable practices ― their obstetricians and GPs will
often not hear about their subsequent visits to abortion
clinics or even the backstreets, especially if it involves an
immigrant later returned to a country in disarray and
perhaps to her 4 children there. [76, 115]. To ensure that
the decision to offer and, if accepted, to perform a TO
during a CS is entirely based on beneficence, a TO dur-
ing a CS should perhaps not involve extra payment to
the obstetrician at all.
There is good evidence that clips for peripartum
TOs ― unfortunately irresistible to gadget aficionados ―
use of which makes extra payment by patient or insurance
unavoidable are certainly not better than sutures while
they are much more costly [7, 48, 116]. Their peripartum
use is completely irrational, even more so if BTS is going
to be the norm.
Although there is no proof of higher TO regret rates if
CS/TO could only be discussed not long before delivery,
there is evidence that this late counselling results in an
increased number of regretted rejections of the TO op-
tion, and therefore unintended pregnancies [76, 96]. It
would be enlightening and ethically responsible, if
readers could please systematically follow up their pa-
tients with two or more children who last delivered by
CS and ask them about their experiences and opinions:
questionnaires to copy available online [76].
As mentioned, higher BMIs [30] and older age are asso-
ciated with increased CS rates [27, 28]. Failure to inform,
in time, in particular such women about their CS risk and
about the inherent TO option, certainly clashes with mod-
ern medical ethics [106]. These are also the very women
for whom other contraceptive options like depot-
medroxyprogesterone-acetate (DMPA), combined hormo-
nal methods, copper intra uterine device (CU-IUD) in
case of sizeable fibroids (fibroids are more prevalent in
African and older women and are also when large
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associated with higher likelihood of venous thrombo-
embolism) tend to be (relatively) contraindicated [31].
Of course, women known to have a BRCA1 or BRCA2
gene mutation and pregnant of what they hope to be
their last child, are also very much entitled to BTS
counselling.
More and more women suffer from ― often age-
related ― subfertility and undergo IVF treatment. These
women have, when the IVF is successful, high CS rates
[29]. Although counterintuitive, they are ideal candidates
for CS/BTS counselling. In case they want another child,
then, preferably, well-planned and quite soon ― not first
struggling for months while ovaries age further, and the
gametes of both partners are somewhat more likely to
become damaged in vivo ― so often again via IVF. Fre-
quently, there will still be some frozen blastocysts, or
perhaps oocytes. In addition, with IVF there is an in-
creased risk of an ectopic pregnancy, but very seldom ―
an interstitial ectopic is still possible ― if there was a
BTS during a previous CS [7, 117]. Couples who are very
grateful that IVF/ICSI made it possible to have the fam-
ily they so eagerly wanted tend to be extra disturbed
when facing an unintended, completely unexpected
(contraception is often thought to be unnecessary), preg-
nancy when she is 38–49 years old. Such women are
regularly seen in abortion clinics but there is seldom
feedback to the IVF doctors and to those who saw her
antenatally and performed the CS [115].
Many women who are around 35 years or older and
who had a CS earlier are in a similar position because
they are not very likely to become pregnant again they
are less prepared to undergo the disadvantages of revers-
ible contraception or jump through the many hoops en
route to an interval TO. For example, in Spain an esti-
mated 840,000 (32%) women aged 40 to 50 years are at
risk of an unwanted pregnancy while 52% of women in
that age group use contraception: mostly (male or fe-
male) PC [118]. In the US, the data are similar. In the
Netherlands 16% of the at risk in this age group is un-
protected, more than three times the proportion of at
risk teenagers (5%) [61].
Less-resourced circumstances
Very disturbingly, in less-resourced regions with a large
unmet need for contraception, around 225 million
women are involved [80], there is a move away from
FPC to other modern methods with more unintended
pregnancies as result [119]. High failure rates, frighten-
ing or irritating side effects [120] could undermine the
cautious trust in the competency of scientific/modern
health care, which must influence compliance in other
areas, such as the advice not to stop anti-TB treatment
too soon, to vaccinate or to make absolutely sure to de-
liver in hospital if the uterus is scarred. The complications
of unintended pregnancies are extra serious in those very
areas [53], not least because often the anti-TOP laws were
largely left untouched after decolonialisation. The result is
that the overall figures show that it is in general about as
dangerous to have a TOP as to continue a pregnancy with
a maternal mortality of about one in 180 in SSA [121].
This while in many other countries the continuation of a
pregnancy is much more likely (a factor 10 in the US) [53]
to end in a maternal death than a― legal, safe, on average
much earlier in pregnancy― TOP does.
Stock outs, lack of infrastructure and transport (many
large, informal, densely populated urban settlements
included), of equipment and properly-paid, well-
supervised health workers, in combination with endur-
ing pronatalist traditions, the authority of the religious
leaders and de facto rural, sometimes urban, health
monopolies of catholic and specific orthodox protestant
hospitals frequently undermine an effective, client-
friendly, integrated approach to contraception [62, 71,
89, 91, 107, 122, 123]. Without guaranteed access to reli-
able contraception and/or well-supervised deliveries (in
SSA about half of the births are assisted by skilled birth
attendants) and/or safe abortion, a CS scar in the uterus
is like a landmine which can still explode 15–20 years
later [96, 124–126]. CSs can moreover result in a mor-
bidly adherent placenta in a subsequent pregnancy with
fatal maternal consequences, even in high-tech US (3%
mortality [36]), let alone in the district hospitals in SSA.
When women have or want more children and therefore
more repeat CS these risks multiply exponentially [36].
Even routine CSs can have high mortality rates in rural/
regional/central hospitals [127, 128]. In the meantime,
CS rates are rising also in less-resourced circumstances
[24, 26, 127].
Doctors working for relief organisations, including
those from countries where very high CS rates are rou-
tine [26], are performing many CSs, and they rarely
combine these with FPC. They often do not ask if pa-
tients with 3–10 children would like a TO because there
are language problems, they assume that women or their
partners (who, by the way, if not physically present, are
frequently telephonable these days) are not interested, or
they are afraid of the husbands like in South Sudan and
they take it for granted that it is unethical to counsel in
a hurry even when there was no earlier antenatal oppor-
tunity to have a “what if you need a CS” talk.
The very fact that relief/NGO doctors are present
makes early/any antenatal counselling, future access to
reliable contraception, well-supervised labour after a
previous CS and professional care for patients with com-
plications of unsafe abortions problematic in both the
short and long term. Tragically, having an unwanted
pregnancy and therefore more often need for a “what if
you need a CS” talk, tends to reduce the chance of
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antenatal care utilisation, just like long clinic waiting
times, poor patient-provider relationships including de-
meaning attitudes, (food) insecurity, stigma, (transport)
costs, staff shortages, cultural beliefs and lack of hus-
band’s permission to travel [123, 128–130].
It seems rather condescending to maintain that a
woman who would remember how she felt when she de-
tected that she was pregnant again, and who has been
pregnant for many months is not in the position, even
as labour has started, to decide whether she would, given
the choice, like to have more pregnancies [106]. Com-
pare that with an ethically cleared randomised study
under patients who just had a ST-segment elevation
myocardial infarction, who are asked to participate in a
study to help detect which percutaneously inserted cor-
onary stent is superior [131]. In both cases we have to
trust that the patients’ benefit ― in the latter case future
patients ― is considered paramount. Working in an en-
vironment, where LARC is largely unavailable, where the
lifetime risk of maternal death can be 1 in 50 as opposed
to 1 in 10,000, where the mortality related to CSs is
100–600 times, the case fatality rate of TOPs 750 times
higher than in the US [53, 127] and where many do not
visit the antenatal clinic, should obviously affect the de-
cision whether to give ― even between contractions ―
say a Para 4 who needs a CS, the TO option or not. Per-
haps a 40% under-five malnutrition/stunting rate in the
area should also be a consideration, or the woman being
(obviously) HIV+.
It is also important to remember that peripartum TOs
if they are consented to in SSA, mostly involve women
who already have 3 or more children before delivery
[16, 18, 102]. For these children it is literally of vital
importance that their mothers stay alive.
Arguably, asking during labour consent for a first CS
(many of which are not lifesaving for the woman and
have serious immediate and future risks) seems more
ethically problematic than providing the TO option if a
CS has already been agreed upon. The consequences of
never having children again are much easier to understand
for a lay person― even for the doctor― than all the pos-
sible future implications of having a CS, especially when
not combined with a TO. Ideally, there is a partner
present or telephonable who supports her either way.
Recently, hospitals and staff in East Congo, North East
Kenya, West Kenya [132] Syria, South East Turkey, Iraq,
Afghanistan, Eastern Ukraine, Yemen and South Sudan
were prevented to work, attacked or became “collateral
damage”, making it difficult to organise well-supervised
labour for those with a scar in the uterus, let alone pro-
vide contraceptive services. Yet, Libya used to have a CS
rate of 26.8% in 2012,Turkey 48%, Syria 19.2%, Ukraine
15.8%, Iraq 14.5%, Afghanistan 4.0%, South Sudan 3.2%
and Mali 2.9%, according to estimates [26]. Combining
the annual number of deliveries (825,000 (population 25
million, crude birth rate 3.3%)) and the past CS rate
(4.8%), it is likely that there must be at a minimum
150,000 fertile women in Yemen with a CS scar in the
uterus [133]. Before the present war 57% of the deliver-
ies was not attended by a doctor or midwife and 38% of
women who delivered did not visit the ANC even once
[133]. Of the women married or living in union aged
15–49 years, 19.2% used modern contraception (global
average 56.1%) of which only a third was independent ―
2.3% FPC, 4% IUD ― of (now largely defunct) supply
networks for injections, pills and condoms [1]. Of the
married women in Yemen, 41% does not want any more
children. The total fertility rate (TFR) is 4.4 children per
woman and the desired TFR 3.1 [133]. At the moment
of writing, food, water, electricity, transport and fuel are
very difficult to obtain, and moreover, in 2013, before
the aerial attacks started, already 41% of under-fives was
stunted and 44% underweight [95, 133].
During the Ebola epidemic in West Africa, routine
hospital work, including antenatal and delivery care,
provision of contraceptives, and anti-HIV therapy more
or less came to a standstill for many months in the rele-
vant areas. Also, it is likely that funds earmarked for
HIV/AIDS assistance in SSA have negatively affected the
capacity to relieve the unmet need for modern contra-
ceptive methods: there is a serious shortfall of resources
for family planning [11, 50]. Moreover, siphoning off
staff into the vertical organised HIV programmes in SSA
seriously interferes with basic health care, including fam-
ily planning and assisting with deliveries [14, 134].
Therefore, there are many places where it borders on
malpractice to perform a CS for a to-be-on-the-safe-side
indication ― e.g. a routine elective CS for breech pres-
entation or a failed misoprostol induction for a some-
what elevated blood pressure, etc. ― if a concurrent TO
is not on offer or not desired by the patient. This used
to be the situation in developed countries certainly hun-
dred years ago when CSs were quite dangerous, modern
contraceptives not available and TO illegal or seen as
unethical [36]. This was often still the case the first 20
years after the Second World War when there was
enough medical staff and equipment, antibiotics, a good
infrastructure making successful referrals possible, reli-
able electricity, and a low incidence of obstetrical fistulae
from prolonged neglected obstructed labour. Parities
were often akin to those presently seen in SSA. There-
fore, CS rates were low, related to the fact that CSs were
about as dangerous as they are presently in many less-
resourced circumstances [104, 127, 128].
Moreover, a WHO report about CSs in SSA states:
“Emergency cesareans, when performed, are often too
late to reduce perinatal deaths” [135]. I remember a few
Para ≥4 who told me after a CS resulting in a stillbirth
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or an early neonatal death that at least we should have
offered a TO because then they would have had some
benefit from the operation: now they feared a future
pregnancy. If they had delivered the deceased foetus
vaginally, often easily possible (if need be with a craniot-
omy), then they would have had the option of a post-
vaginal delivery minilap TO. Very few doctors are
prepared to perform such a TO soon after a CS.
In quite some less-resourced settings, uterine ruptures,
fatal obstetric haemorrhage associated with CS deliveries
and obstetric fistulae develop even when women labour
in health facilities [125, 128, 136, 137]. One can imagine
the danger if women with a scar in the uterus avoid hos-
pital deliveries [138] or can’t reach a reasonably
equipped/staffed medical facility in time. Therefore, ar-
guably, as long as obstetric fistulae are not uncommon
in a certain region, a CS should only be performed if
there is (also) a solid maternal indication, unless the pa-
tient and perhaps the family too, is properly counselled
about the future risks, or alternatively, the patient elects
to have a concurrent TO. It follows that, besides protest-
ing TO counselling performed under time pressure
[101] in situations where a CS scar is quite dangerous
and where earlier “what if” counselling about the options
in case of a CS, was not done or not feasible [96], the
ethicists should also worry about the absence of emer-
gency counselling vis-à-vis the potential consequences of
not performing a concurrent TO [127, 128]. There is a
tendency in low-resourced areas to believe, and there is
outside encouragement [26], that “Western” or perhaps
Chinese CS rates are needed for optimal obstetrical care
[139], while the high-tech facilities, staff, drugs, contra-
ceptives (prevalence of modern contraception in SSA is
1/4–1/3 of the global figure [1]) and the availability of
safe abortions are seldom guaranteed, to limit the dan-
gers. One step in the right direction would be that rele-
vant women are always provided ― preferably
antenatally ― by the TO option.
It would be very good if the international community
would donate enough LARC. It might, in the long run,
contribute more to global misery-prevention than any
other assistance [10, 11, 122, 140, 141]. Of course, as
stated, this is not easily implemented because of weak
medical system infrastructures [57, 96, 98, 122, 134,
142]. One often reads reports about enthusiastic accept-
ance of IUDs, implants, and TO under local anaesthesia
during donor-funded drives with generous per diem al-
lowances for trainees and perhaps transport refunds for
the clients, but integrating these services year after year
in the daily routine ― postpartum or post admission
after a clandestine abortion, would often be easiest for
the women, plus a walk-in reproductive health clinic ―
is quite another story [143, 144]. Moreover, IUDs are
sometimes expulsed or they partly descend therefore
they need longer and more well-equipped medical back-
up than TOs [55, 145]. This also applies to IUDs fitted
during a CS or within 48 h of a vaginal delivery. If the
family is complete, the associated 5–10% expulsion rate,
often unrecognised by the woman and in practice and
when the strings are not visible not easily excluded in
clinics ― most having no ultrasound or X-ray facilities ―
is well-nigh unacceptable. Implants, which can be inserted
before hospital discharge after delivery or after abortion/
miscarriage, need very little aftercare till the next insertion
but irregular bleedings can be very bothersome/fear
inducing. It could be, however, that women in SSA
are more prepared to accept these inconveniences, as
with injectable contraceptives, because they often per-
sonally knew women who died of a pregnancy or they
nearly did this themselves, and they often have no
proper alternatives [140, 146].
In some less-resourced circumstances the risk of re-
gret following PC is increased, for example in parts of
India. There childbearing still starts young while desired
family size has decreased substantially. Women may
have what they consider a completed family at age 22–
24 years. The chance of a regretted TO, because of loss
of the partner or a child, is quite high in such settings,
and there is seldom access to tubal reconstruction/IVF
[147]. Access to LARC ― contraceptive injections are
too controversial in India but popular in Thailand,
Indonesia, Bangladesh and Sri Lanka [1] ― to postpone
TO for 10 years or so, or, when satisfied, for continu-
ation, would help. Alternatively, at some stage, it would
probably also make economic sense for India ― re-
nowned for “fertility tourism” ―, and also for example
for Indonesia, with a 12% and fast increasing CS rate
[26, 148], to have a low threshold for both TO counsel-
ling and gratis IVF provision if a partner or child has
died ― as has happened in China after an earthquake
killed many children [76]. Conversely, the few TOs cur-
rently performed in large areas of SSA often involve
older women who regularly have 1–3 children more
than originally desired [16, 18, 96, 102, 141] and who,
moreover, are likely to have, orphans in the extended
family who need them also [149].
In SSA, FPC is not often routinely antenatally dis-
cussed unless there is a strong medical indication like in
anticipation of the 3rd-5th CS. For example, a paper
from Ghana about pregnancies in HIV-infected women
states: “This may call for a new approach in which
healthcare providers initiate such discussions (i.e. about
patients’ reproductive intentions) with women living
with HIV” [150]. This suggests that women who are not
known to be HIV positive will for the time being lack
this very basic service.
Medical teachers and role models, mostly city-based,
tend to promote the high-tech optical instrument TO
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approach, giving doctors in training the false impression
that using basic technologies for peripartum and interval
TO is lacklustre and obsolete [48]. Those young doctors
could later, e.g. as district doctor in Africa or Asia, be
handicapped as PC-providers because of lack of fancy
instruments.
Very fortunately, otherwise some regions would have
very bleak futures, and contrary to conventional wisdom,
voluntary contraception will not become widespread
only when standards of living and education have im-
proved. After initial acceptance of family planning by
opinion leaders, the availability of modern contraception
itself, including dedicated pro-active services, drives the
decrease in pregnancy rates [11, 151].
A form of government or donor incentive for staff per-
forming vasectomies, post vaginal delivery and interval
TOs ― probably not a salpingectomy during CS because
that requires very little effort, and the extra payment
might just sometimes turn out to be too tempting ― is
advised [96, 152]. Private gynaecologists all over the
world earn often hundreds of dollars with these proce-
dures with nobody raising ethical concerns about in-
ducements [39]. This while many would frown upon an
African or Asian government doctor receiving say 25
dollars extra. As if the latter would be more inclined to
compromise his/her patients’ interests [18, 153]. Many
of these government doctors are allowed some add-
itional private practice because the state is unable to
provide an ― arguably ― reasonable salary. The $25
would then recompense lost income. Even very well-to-
do GPs in many rich countries receive government in-
centives for influenza vaccinations, and for diabetes and
cervix screening, while it is just an easy part of their job.
One could also argue that private obstetricians in some
countries have an incentive to discourage CS/TO, even
if only 50% of their patients return for a hysteroscopic/
laparoscopic TO later.
HIV/AIDS
In 2009, 370,000 children became newly infected with
HIV. These tragedies often started as unintended preg-
nancies, while the woman knew, suspected or could not
exclude that she was HIV positive [71, 154–156]. By
2013, vertical HIV transmissions had declined to around
200,000, not really because there were fewer unintended
pregnancies of HIV positive women but because of bet-
ter access to screening and anti-HIV therapy of pregnant
and breast feeding women [156]. Since the advice is to
start treating HIV+ children (and recently also adults)
immediately after diagnosis, the vertical HIV infected
ask ― hopefully for at least eighty years per child ― a
gigantic financial and manpower commitment (billions
of dollars) that is unlikely to be sustainable [134, 157].
According to UNICEF, in 2014, there were 2.6 million
HIV+ under-15 children globally, most of whom were
vertically infected and only one in three was on treat-
ment. AIDS is the number one cause of death in Africa
among adolescents (10–19 years). Adolescent AIDS
deaths have tripled since 2000. Moreover, presently 13.3
million children (0–17 years) have lost one or both par-
ents to AIDS [158].
The above suggests yet again, that far more misery is
caused by not giving potentially interested women the
option of a TO if an opportunity arises, than by provid-
ing the TO option, even, if forced by circumstances, in a
hurry. In many cases, any health worker who has seen
the woman antenatally, or even earlier at the HIV clinic,
and did not discuss and record her reproductive inten-
tions and did not assist her to attain those goals, be-
haved unprofessionally: not, it is suggested, the doctor
who provided, albeit between contractions, the TO op-
tion in suitable cases.
There is now a fast-growing group of HIV+ women
who have a completed family, are older than 30 years
and would benefit from PC. There are communities in
SSA where more than 50% of pregnant women of 30
years and older are HIV positive while at the same time
childbearing starts very young [159]. Although proper
HIV therapy will suppress the virus so well that vertical
HIV transmission becomes unlikely, stopping medica-
tion because of supply or motivation problems, an Ebola
outbreak or donor fatigue, might soon result in a serious
vertical transmission risk. Therefore contraception
should be very reliable and preferably resistant to public
disturbance and economic collapse. In SSA, combined
oral contraception has very high typical failure rates [96,
146]. Three-monthly DMPA injections are however
quite popular (nearly nine million users, prevalence
6.8%; the most used modern method in SSA [1]), though
there is still much unmet demand [10, 146] and in prac-
tice ― with a typical first year failure rate of 6% in the
US [34] where the medication would be very seldom out
of stock ― often the most reliable realistic reversible op-
tion for mothers with a completed family. Except, 6% is
of course too much if the consequences are potentially
so very dramatic, on top of that there is a large discon-
tinuation rate because of side effects. A study from
Malawi of HIV+ women on treatment showed that after
48 months 2/3 of injection users were still using the
method, the same applied to CU-IUDs [130]. A South
African study of both copper IUDs and progestin
contraceptive injections involving women who requested
long-term protection, showed failure and discontinu-
ation rates similar to the above [160]. There is some evi-
dence that DMPA increases the risk of horizontal HIV
transmission and acquisition to a degree [160–162].
Thorough risk-benefit calculations, however, do not
come out in favour of abolishing DMPA under most
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circumstances [146]. The injections prevent many ma-
ternal deaths and vertical HIV infections by averting un-
intended pregnancies [10, 96]. But these nuances might
get lost when tabloids and/or persons with different
agendas become involved, which has happened before in
relation to this method [143], see also Wikipedia.
Women with a completed family who have been offered
and have accepted an opportunistic TO might consider
themselves exceptionally lucky in future if DMPA is un-
obtainable because of physicians’ and nurses’ strikes, be-
cause USAID lost funding or because of civil war with
perhaps many cases of rape [163, 164].
It might also be a good idea to offer family planning
clients HIV tests ― if it does not stigmatise and hence
deter visitors ― in order to perhaps adjust the method
advised in accordance with the HIV test result and in-
form clients about the PC-option in case an opportunity
present itself in future.
Men
Of course, what’s good for the goose is good for the gan-
der. Men in some West European countries, such as
France, have very low vasectomy rates compared to
those in comparable countries (US, Canada (including
the Québécois), United Kingdom, Australia, New
Zealand, South Korea, Switzerland, Czech Republic,
Spain, Netherlands, Denmark) [1]. These are historical,
legal and cultural coincidences, which need, it is sug-
gested, evidence-based reconsideration. Other countries
with sizeable vasectomy prevalence percentages are
Bhutan (13.6), Nepal (6.3), China (4.5), Puerto Rico (5.3)
and Brazil (5.1) [1]. Men can, not seldom the more edu-
cated ones do, contribute with vasectomies. It’s only fair,
i.e., their partners were troubled for years as a result of
their reproduction-friendly evolutionary design, by
bothersome periods, the final responsibility ― in prac-
tice ― for contraception, including often the side effects
and costs, perhaps TOPs, miscarriages, nausea, painful
deliveries, breast afflictions, striae, candida infections,
cystitides, cervical screenings and other inconveniences.
Opportunistic vasectomies are sometimes an option in
combination with inguinal hernia and hydrocele opera-
tions. Moreover, 10 million voluntary male circumcisions
were performed in the years before 2016 (the aim was
20.9 million) to reduce HIV transmission in high-risk
countries [165]. Perhaps some men ― but most would
be too young ― would have been interested in a concur-
rent vasectomy.
Conclusion
Facilitating the prevention of unintended pregnancies,
which should involve inquiring about reproductive in-
tentions, is one of the easiest and most important contri-
butions doctors, midwives and nurses can make to
individual and collective misery prevention. Without
extra efforts, in which a larger role of PC appears essen-
tial, the United Nations 2030 Sustainable Development
Goals [166] will not be attained. Perhaps population
pressures and the associated upheavals will destabilise
whole (sub) continents, in turn making it much more
difficult to provide reproductive health services [109, 167].
Although around 270,000 maternal deaths and an esti-
mated 230 million births ― 1.7 times the current number
of livebirths ― are already averted annually by present
global contraceptive use [12] another 21 million deliveries,
and 26 million TOPs [23], would probably be
avoided if the unmet need for reliable contraception
was satisfied [80].
Opinion leaders, including doctors in countries with
high birth rates, should propagate/demonstrate the idea
that quality often tops quantity of offspring because it
results in more resources per child including better edu-
cation and less overall poverty. There are no medical
reasons, but PC is exceedingly rare in some countries,
while in others, PC (male or female) protects more than
40% of the women who are married or living in union.
Globally, the average is estimated to be 21.3%. Further-
more, when comparing countries where PC is common,
one notices enormous variations in the relative preva-
lence of male (highest in Canada, 22.0%) and female
(highest in the Dominican Republic, 47.4%) PC [1].
Therefore, there must be scope, if excellent services are
made available, to provide more PC services, especially
in Africa, Europe and the Middle East.
Relying on PC is a very convenient state of affairs for
many with a completed family. It provides peace of
mind. However, the need for an operation can be quite a
barrier (fear, costs, logistics, scarcity of relevant profes-
sionals), when female PC is not combinable with a deliv-
ery, especially a CS, or abortion. PC is certainly not just
suitable for the poor. There are millions of well-to-do
couples in places like the UK, Spain, Finland, Norway,
Switzerland, North America, Latin America, East Asia,
Thailand, Australia and New Zealand, quite satisfied
with either male or female PC [1]. On the other hand, it
is not that difficult in well-resourced circumstances with
accessible TOP services for a large part of the population
to attain its reproductive goals safely without PC ― al-
though it typically involves more stress, side effects and
unintended pregnancies. However, there are often disad-
vantaged women with a completed family in rich coun-
tries for whom it is rather difficult to have no
unintended children without PC [17, 92]. Poor women
in the US have an unplanned birth nearly seven times as
often as higher-income women [57]. Overall, TOP rates
in developed countries have declined recently but there
is a shift towards married women and, for example, in
England and Wales over de last 10 years TOP rates of
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women over 30 increased significantly [23, 168]. European
women are more often married (70%) than North
American women who have TOPs (41%) [23]. There
are many contributing factors but it seems likely that
the large difference in PC prevalence ― 5.6% and
36% respectively [1] ― is important, because many/
most unwanted pregnancies in these continents are
related to inconsistent or imperfect use or failure of
reversible contraception [23, 53, 57].
Women who aim to have few children will not easily
succeed in less-resourced countries without PC, unless
they have ― often unsafe ― TOPs [13, 80, 82]. Imagine
a mother of five (whose first, fourth and fifth pregnancy
started as unintended conceptions) expected to travel 30
km to the nearest clinic every three months from age 32
till 50 for contraceptive injections, which may be some-
times out of stock, while transport costs reduce food
and schooling available to her children. Perhaps she will
develop a contra-indication like high blood pressure at
age 35. This woman delivered by CS the last time but
she was not given the option of a concurrent TO, and
the doctor who operated her will rarely hear about her
plight, just like there is often no feedback in developed
countries [115].
As discussed, recent developments have made PC a
more attractive option for more women, with less risk of
regret and failure, mainly because employed and more-
educated ― and therefore presumably less coercible ―
women in many places are older when they consider
their family complete, and because child mortality has
decreased substantially ― but there is a risk that popula-
tion growth will reverse progress and then this window
of opportunity might close.
Increasing CS rates have made PC accessible to more
mothers while those extra CSs simultaneously result in
more women for whom it can be dangerous not to have
a TO. Especially women without guaranteed access to
reliable contraception, well-supervised labour and/or
safe abortions run a serious risk with a scarred uterus
even in referral hospitals [169]. Providing the relevant
women/couples with the option of a total salpingectomy
might save more money on unneeded contraceptive
methods/consultations, TOPs, treatments of the compli-
cations of unsafe TOPs, and ovarian cancer therapy, than
it might cost to provide IVF ― increasingly available in
capitals ― to the few with serious regretted PC. Few
health systems can afford to squander PC counselling
opportunities.
During pregnancy, “what if you need a CS” explora-
tions are needed about the perinatal PC option, if at all
possible weeks before the expected delivery date, as
FIGO advises [96, 101]. Yet denying women/couples that
choice is an unethical and careless routine in many
countries. The antenatal software/paper records should
be adapted to prompt well-timed counselling and infor-
mation leaflets, and informational posters ought to be
provided in the antenatal clinics. The media also have an
educational role to play.
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